TrialHuman vaccines & immunotherapeutics2026

Heterologous prime-boost vaccination against H5 avian influenza: Safety and immunogenicity of a MF59-adjuvanted, cell-culture derived H5N6 vaccine.

Esther Van Twuijver et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.